Osteoarthritis Trial, Recruiting NCT06195423 Sponsor: University of British Columbia Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06195423
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who currently live in British Columbia, Canada
  • People who are between 16 and 35 years old (inclusive)
  • People who are 9 to 36 months past their first ACL reconstruction surgery, where that surgery happened within 12 months of their first ACL tear
  • People who are not currently receiving any knee care from a health or fitness professional, and who have no upcoming surgeries (on any part of the body) that would interfere with exercise during the study
  • People whose knee function scores fall below a certain threshold on a standard knee health questionnaire (fewer than 79 points on the KOOS4 scale)
  • People who have daily access to an email address and a computer with internet
  • People who are willing to wear an activity tracker throughout the study

Who may not be able to join:

  • People who are unable to communicate in English
  • People who have had a significant injury to the reconstructed knee (one that caused them to miss physical activity, sport, or work on two or more occasions) prior to their original ACL tear
  • People who have previously been diagnosed by a doctor with osteoarthritis in the knee that was operated on
  • People who have inflammatory arthritis or another condition that affects the whole body
  • People who have had an injury, surgery, or injection into a joint in either leg in the past 6 months
  • People who are currently pregnant
  • People who are unable to have an MRI scan, which may include: people who weigh over 400 lbs; people with a pacemaker or certain other implanted medical devices (such as a defibrillator, artificial heart valve, drug pump, nerve or bone stimulator, certain catheters or filters in blood vessels, ear or eye implants, or a stainless steel IUD); people with a metal clip in the brain; people with any other metal implants, fragments, or foreign objects in the body, including shrapnel or metal that may have entered the eye; or people who have had surgery, a medical procedure, or a tattoo (including tattooed eyeliner) in the last 6 weeks (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jackie L Whittaker, BScPT, PhD, University of British Columbia

Phone: 604-202-1362

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
30 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Self-reported knee-related pain, symptoms, function in sport and quality of life over 6 months (effectiveness outcome) (ACL tear participants); Incremental cost-utility ratio over 6 months (efficiency outcome); Provider adoption of SOAR over 6 months (implementation outcome) (physiotherapist participants)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov